Lubrizol creates a new magnesium prototype that is able to melt-in-your-mouth.
A recent press release announced that Lubrizol Life Science created a prototype formulation that contains its trademarked Magshape microcapsules. Magnesium aids in assisting the body with maintaining a stable heart rhythm, normalizing blood pressure, and keeping bones strong (1). The magnesium formulation by Lubrizol is contained in a fast-melt powdered stick. The press release mentioned that it can be used as a convenient supplement method for “on-the-go-work-outs” and as a daily magnesium boost.
The prototype delivers Magshape microcapsules in an orosoluble stick that melts in your mouth to distribute “250mg elemental magnesium (upper limit of magnesium in a food supplement recommended by the European Food Safety Authority (EFSA))”, into the body. The 250mg single dose is packaged in a 1.5g sachet of powder. Magshape is offered as both tablets and chewables (2).
“Orosoluble powders that can deliver uniform palatable doses of magnesium require significant expertise to develop successfully,” mentioned Alan Connolly, Lubrizol's R&D manager. “It involves striking the right balance between particle size, solubility, taste, and flowability. Too large a particle size will result in poor dispersion in the mouth leading to a gritty, unpleasant texture. However, even the smallest particle will not behave as expected if it displays poor orosolubility.”
According to the press release, magnesium can be utilized as a supplement to help reduce stress and promote muscle relaxation. The nutritional supplement is approved by the EFSA for its functional capabilities in protein synthesis, normal energy-wielding metabolism, electrolyte balance, and normal muscle function. Magnesium also aids in decreasing fatigue and tiredness which is an attractive benefit for athletes.
“Magnesium supplementation is widely embraced to bridge some nutritional gaps,” said Isabel Gómez, global marketing manager for Lubrizol Nutraceutical business. “However, obtaining the daily recommended dose can be burdensome, whether due to large pill sizes, their tendency to leave an unpleasant taste in the mouth, or gut discomfort, which consequently indicates poor absorption. Magshape magnesium ingredient was uniquely designed to ease the routine of supplementing by concentrating a potent dose of magnesium into the smallest serving while also being microencapsulated to ensure its absorption and minimize side effects.”
Lubrizol’s press release explains how the microencapsulation technology found in the Magshape supplement offers micronized magnesium oxide particles with a broader surface area. With this technology, the magnesium is absorbed slowly in the intestinal tract which helps in lowering undesirable side effects experienced with magnesium supplements. The press release continued to mention how the Magshape microencapsulated magnesium can be seen as more appealing due to its various consumption options.
“Magshape ingredient is crafted from magnesium oxide which is the most concentrated form of magnesium. Its microencapsulation is designed to support gradual assimilation throughout the entire digestive system so that more gets into the blood stream to help replenish and maintain healthy magnesium levels in human cells and bones,” Gómez commented. “A bioavailability study is in the pipeline to confirm its bioactivity in the body.”
References
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.